DOCSLIB.ORG

P53 Prevents Neurodegeneration by Regulating Synaptic Genes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
P53 Prevents Neurodegeneration by Regulating Synaptic Genes p53 prevents neurodegeneration by regulating synaptic genes Paola Merloa, Bess Frosta, Shouyong Pengb,c, Yawei J. Yangd,e,f, Peter J. Parkc,g, and Mel Feanya,1 Departments of aPathology and cMedicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; bDepartment of Medical Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; dDivision of Genetics and Manton Center for Orphan Disease Research, Children’s Hospital Boston, Boston, MA 02115; eBroad Institute of MIT and Harvard, fHoward Hughes Medical Institute, Cambridge, MA 02142; and gCenter for Biomedical Informatics, Harvard Medical School, Boston, MA 02115 Edited by Nancy M. Bonini, University of Pennsylvania, Philadelphia, PA, and approved October 30, 2014 (received for review October 8, 2014) DNA damage has been implicated in neurodegenerative disorders, Here we show that p53 is neuroprotective in an in vivo model including Alzheimer’s disease and other tauopathies, but the con- of tauopathy. Through chromatin immunoprecipitation (ChIP)- sequences of genotoxic stress to postmitotic neurons are poorly chip analyses we determine that p53 controls the transcription of understood. Here we demonstrate that p53, a key mediator of the a group of genes involved in synaptic function. Genetic manipu- DNA damage response, plays a neuroprotective role in a Drosophila lation of these genes modifies tau neurotoxicity. We find that the model of tauopathy. Further, through a whole-genome ChIP-chip transcriptional control by p53 of these synaptic genes is conserved analysis, we identify genes controlled by p53 in postmitotic neu- in murine neurons and human brain. Our results thus implicate rons. We genetically validate a specific pathway, synaptic function, synaptic function as a critical p53 target in neuroprotection. in p53-mediated neuroprotection. We then demonstrate that the control of synaptic genes by p53 is conserved in mammals. Collec- Results tively, our results implicate synaptic function as a central target in p53 Protects from Neurodegeneration During Aging in Vivo. To in- p53-dependent protection from neurodegeneration. vestigate the role of p53 in tauopathy pathogenesis, we first expressed tau in flies lacking p53 (Fig. 1A). Although p53-null p53 transcriptional function | ChIP-chip | neurodegeneration | tauopathy | flies showed no evidence of neurodegeneration in the absence of synaptic genes transgenic human tau (Fig. 1 B–D), cell death, as measured by the number of TUNEL-positive neurons, significantly increased 11-1B-1 eurodegenerative diseases are a group of inexorably pro- in the brains of tau-expressing, p53 (p53 )-null animals Ngressive disorders characterized by ongoing dysfunction and compared with tau-transgenic animals with normal levels of en- death of postmitotic neurons and are among the principal causes of dogenous p53 (Fig. 1B and Fig. S1A, Left). Neurodegeneration in morbidity and mortality associated with aging (1–3). Tauopathies, our model, as in mouse tauopathy models and in Alzheimer’s including Alzheimer’s disease, are defined neuropathologically by disease, is associated with abnormal reactivation of the cell cycle aggregation and deposition of the microtubule-associated protein in postmitotic neurons (Fig. S1B) (5, 6, 14, 15). Removing p53 tau accompanying neuronal loss (1–3). DNA damage has been from tau-transgenic flies significantly increased cell-cycle reac- NEUROSCIENCE documented in neurodegenerative disorders, including tauopathies, tivation, as measured by proliferating cell nuclear antigen but the effects of DNA damage on the function and viability of (PCNA) reexpression in neurons (Fig. 1C and Fig. S1A, Right). nondividing neurons are poorly understood (4–6). Enhancement of human tau-driven neuronal death and cell-cycle reactivation was also observed when a second p53 null allele In this study, we used a Drosophila model of tauopathy based 5A-1-4 on expression of human tau carrying the R406W mutation, which (p53 ; Fig. S1 C and D) was used to remove p53 function. To is found in patients with the familial tauopathy frontotemporal dementia with Parkinsonism linked to chromosome 17 (7). Our Significance model recapitulates several key features of human tauopathies, including accumulation of abnormally phosphorylated and con- The transcription factor p53 plays a critical role in the cellular formationally altered tau, age-dependent neurodegeneration, response to DNA damage and has thus been studied in- and early death (7). We have previously shown that expression of tensively in oncogenesis research. However, the role that p53 human tau in Drosophila neurons induces the DNA damage plays in the response of postmitotic neurons to cellular stress response, including p53 up-regulation, and that reducing the has received less attention. Here we describe an unexpected function of the DNA damage checkpoint significantly increases neuroprotective role for p53 in an in vivo model of tau-medi- neurodegeneration (5). These data suggest an unexpected neu- ated neurodegeneration relevant to Alzheimer’s disease and roprotective role for p53 in postmitotic neurons. We were related disorders. Further, we identify synaptic function as therefore motivated to examine the transcriptional function of a novel target pathway for p53 in aging neurons, consistent p53 in the context of progressive neurodegeneration. with the growing evidence for synaptic pathology as an early p53, together with p63 and p73, comprises a family of tran- event in neurodegenerative disease. Our study defines mech- scription factors, which regulate fundamental processes including anistically a new, conserved role for p53 in protecting post- proliferation, differentiation, senescence, and cell death (8, 9). The mitotic neurons from degeneration during aging and disease. p53 family has been extensively studied in tumorigenesis, but the Author contributions: P.M. and M.F. designed research; P.M., B.F., Y.J.Y., and M.F. per- role of family members in postmitotic neurons is poorly defined, formed research; P.M. contributed new reagents/analytic tools; P.M., S.P., P.J.P., and M.F. with an emerging body of literature suggesting involvement of the analyzed data; and P.M. and M.F. wrote the paper. p73 subfamily in aspects of neuronal development and neuro- The authors declare no conflict of interest. – degeneration (10 12). Using Drosophila to study p53-dependent This article is a PNAS Direct Submission. transcription in neurodegeneration has two significant advantages. Data deposition: The data reported in this paper have been deposited in the Gene Ex- First, transcription can be studied in aging neurons in vivo. Second, pression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE40418). analysis of overall p53 family function in a simplified genome, 1To whom correspondence should be addressed. Email: [email protected]. “ ” which contains a single p53 gene, may reveal ancestral activities This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. of the family (9, 13). 1073/pnas.1419083111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1419083111 PNAS | December 16, 2014 | vol. 111 | no. 50 | 18055–18060 Downloaded by guest on September 30, 2021 AB with p53 if they had binding peaks in the promoter region, de- fined as 2 kb upstream and 1 kb downstream of the annotated transcriptional start site. Examination of the ChIP-chip data 60 *** ctr p53 nulltau tau + p53 null 50 revealed that p53 binds the promoter region of ∼1,500 genes in ∼ a-tau 40 tau-transgenic flies, of which 550 showed significant enrich- 30 ment in tau-expressing neurons compared with controls [false a-actin 20 discovery rate (FDR) < 0.01; Fig. 2B]. To provide a compre- 10 hensive picture of p53 transcriptional function in postmitotic p53 wt # TUNEL positive cells TUNEL # 0 neurons, we included the entire list of 1,500 genes bound in tau- p53 mut ctr p53 null tau tau + transgenic animals in our subsequent analyses (Dataset S1). p53 null An important physiological role for the p53 targets we iden- CD tified here is consistent with our previous recovery of th, par-1, 120 *** 35 *** Tao, cdi, chb, aop, dally, and Fmr1 in an unbiased forward genetic 100 30 screen for modifiers of tau neurotoxicity (19). Each of these 80 25 genes was bound by p53 in the present ChIP-chip experiment. 60 20 Similarly, a number of the genes that we have previously shown 15 *** 40 10 to control tau neurotoxicity in pathway-focused studies are also # PCNA foci # PCNA 20 (cm / 30 sec) walking speed 5 p53 targets: hep, Act5C, Drp1, sqh, WASp, zip, PHGPx, CycD,and 0 0 eIF-4E (5, 6, 20–22). In addition, the list of genes bound by p53 ctr p53 null tau tau + ctr p53 null tau tau + in our ChIP-chip experiment includes cell-cycle regulators (p53, p53 null p53 null Gadd45, CycD, Cdt1, and Msh2). Recovery of these cell-cycle genes is consistent with genetic evidence supporting a neuro- Fig. 1. p53 is neuroprotective in Drosophila tauopathy. (A, Upper) Tau protein levels do not change in p53-null flies. (Lower) Genomic PCR analysis protective, rather than proapoptotic, role for the DNA damage confirms genotypes at the p53 locus for the animals used. (B) Apoptosis, checkpoint in postmitotic neurons (5, 6). Of note, vertebrate indicated by TUNEL-positive neurons, increases in the brains of tau-trans- homologs of p53, Gadd45, CycD, Cdt1, and Msh2 are known p53 genic, p53-null animals. (C) Cell-cycle reactivation, indicated by PCNA-posi- targets, supporting conservation of p53 binding and function tive foci, increases in the brains of tau-transgenic, p53-null animals. In B and from flies to mammals (18, 23, 24). C, flies are 10-d-old (n ≥ 6 per genotype). (D) Removing p53 in tau-transgenic We next determined whether particular cellular pathways were animals worsens locomotion, measured as walking speed. Flies are 2-d-old enriched for p53 binding. We used the list of p53 target genes (n = 18 per genotype). In the graph, values represent mean ± SEM. Asterisks indicate significant differences compared with control by ANOVA with Student–Newman–Keuls post hoc test for multiple comparisons.
Load more

Recommended publications
  • Chemical Composition and Pharmacological Mechanism of Ephedra- Glycyrrhiza Drug Pair Against Coronavirus Disease 2019 (COVID-19)
    www.aging-us.com AGING 2021, Vol. 13, No. 4 Research Paper Chemical composition and pharmacological mechanism of ephedra- glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19) Xiaoling Li1,*, Qin Qiu2,*, Mingyue Li3,*, Haowen Lin4, Shilin Cao5,6, Qu Wang4, Zishi Chen5, Wenhao Jiang5, Wen Zhang7, Yuge Huang8, Hui Luo9, Lianxiang Luo9,10 1Animal Experiment Center of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 2Graduate School of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 3Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA 4The First Clinical College of Guangdong Medical University, Zhanjiang 524023, Guangdong, China 5Group of Sustainable Biochemical Engineering, School of Food Science and Engineering, Foshan University, Foshan 528000, Guangdong, China 6Sustainable Biochemical and Biosynthetic Engineering Center, Foshan Wu-Yuan Biotechnology Co., Ltd., Guangdong Biomedical Industrial Base, Foshan 528000, Guangdong, China 7Aditegen LLC, Jersey, NJ 07310, USA 8Department of Pediatrics, the Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China 9The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, Guangdong, China 10Marine Medical Research Institute of Zhanjiang, Zhanjiang 524023, Guangdong, China *Equal contribution Correspondence to: Lianxiang Luo; email: [email protected] Keywords: COVID-19, ephedra, glycyrrhiza, network pharmacology, molecular docking Received: August 26, 2020 Accepted: November 30, 2020 Published: February 13, 2021 Copyright: © 2021 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Traditional Chinese medicine (TCM) had demonstrated effectiveness in the prevention and control of COVID-19.
    [Show full text]
  • Twists and Turns in Protein Assembly
    Twists and Turns in Protein Assembly Professor Robert Fairman TWISTS AND TURNS IN PROTEIN ASSEMBLY In nerve cells, the accumulation of protein into bundles of insoluble fibres is the underlying cause of a number of neurodegenerative diseases. Professor Robert Fairman and his team at Haverford College are developing cutting edge techniques to unravel this process. Proteins are the building blocks of life. The leads to the death of particularly vulnerable genetic code within each cell of our bodies cells such as neurones – the elaborate and controls the sequence of molecules called sensitive cells in our brain. This is the basic amino acids, which assemble together mechanism that causes the debilitating and to form each protein. But this is only the currently untreatable neurological disorder first step. Amino acids are small charged Huntington’s disease, which is characterised molecules that interact with one another as by a disruption of normal movements and they join together to form strings of peptides a decline in mental ability, resulting in (polypeptides), which spontaneously develop dementia. into different structures known as secondary structures. This can involve the formation ‘The relationship of this aggregation to of sheets or helical spirals following certain disease is poorly understood, and differences rules determined by the order of the amino in protein structure may underlie differences acids. These secondary structures then in toxicity,’ Professor Fairman admits. ‘Many interact with one another to form larger neurodegenerative diseases (Alzheimer’s, tertiary structures of proteins that control Huntington’s, Parkinson’s) have a similar and mediate every aspect of cell function. underlying molecular mechanism of protein aggregation, involving the formation of ‘Ever since I was an undergraduate student, an extended polypeptide chain that can I’ve always been fascinated with a chemical aggregate through ß-sheet formation.’ view of biology,’ Professor Fairman tells As such, it is vital to understand how Scientia.
    [Show full text]
  • From the President's Desk
    Sept | Oct 2009 From the President’s desk: The Increasing Importance of Model Organism Research I’m sure you know this scenario: You’re at a party, and someone hears you’re a biologist, and asks, “What do you work on?” When this happens to me, and I respond that I study yeast, I frequently get the follow-up question that you have probably already anticipated: “Are you learning how to make better beer?” At that point, I offer my explanation about the value of studying model organisms, which in cludes the statement that my daughter, now 17, learned to repeat with me by the time she was 3: “Yeast are actually a lot like people.” If you study a model organism, whether it’s yeast, bacteria, phage, flies, worms, fish, plants, or something else, you probably have been in Fred Winston a similar situation when talking to someone who is not a scientist. There GSA President is little understanding among the general public about the value of studying a model organism. This is also true among some who we might think would better understand this issue. While you wouldn’t be surprised to learn that the person at this party was a lawyer or a businessperson, you might also not be too surprised if that person turned out to be a physician, or even a human biologist. Even among some biologists who understand the history of model organisms, there may be a lack of appreciation for what model organism research can contribute to future scientific understanding. For these scientists, model organi sms appear to be in the twilight of their usefulness with the advent of new sequencing technologies and other genome-wide, high-throughput approaches that can be used in human studies.
    [Show full text]
  • 'Epigenetic Landscape' Is Protective in Normal Aging, Impaired in Alzheimer's Disease 5 March 2018
    'Epigenetic landscape' is protective in normal aging, impaired in Alzheimer's disease 5 March 2018 compaction of chromosomes in the nucleus (called acetylation of lysine 16 on histone H4, or H4K16ac for short). Changes to the way H4K16ac is modified along the genome in disease versus normal aging brains may signify places for future drug development. Because changes in H4K16ac govern how genes are expressed, the location and amount of epigenetic alterations is called the "epigenetic landscape." "This is the first time that we have been able to look at these relationships in human tissue by using donated postmortem brain tissue from the Penn Brain Bank," said Shelley Berger, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine and a professor of Biology in the School of Arts and Sciences. "Our results Coronal section of human brain indicating the lateral establish the basis for an epigenetic link between temporal lobe (red circle) used in this study. Credit: aging and Alzheimer's disease." Coronal section of human brain indicating The lab of Shelley Berger, PhD, Perelman School of Medicine, Berger, also the director of the Penn Epigenetics University of Pennsylvania Institute, Nancy Bonini, PhD, a professor of Biology, and Brad Johnson, MD, PhD, an associate professor of Pathology and Laboratory Medicine, are co-senior authors of the new study. Although certain genetic variants increase the risk of Alzheimer's disease (AD), age is the strongest H4K16ac is a key modification in human health known risk factor. But the way in which molecular because it regulates cellular responses to stress processes of aging predispose people to AD, or and to DNA damage.
    [Show full text]
  • St. Geme Symposium Pediatrics, University of Sponsored by the Colorado, AMC Section of Developmental Biology
    Department of St. Geme Symposium Pediatrics, University of Sponsored by the Colorado, AMC Section of Developmental Biology September 10, 2020 2:00pm-4:00pm Speaking Schedule Introduction by Dr. Bruce Appel, Section Head, The St. Geme Symposium Developmental Biology will be held this year in association with the St. 2:00 Caleb Doll, PhD – Fragility in specification; roles for Geme Lectureship, an the RNA binding protein FMRP in gliogenesis annual event in honor of 2:15 Agnese Kocere – RBM8A deficiency in TAR syndrome Dr. Joseph St. Geme, a impacts the lateral plate mesoderm former Dean of the 2:30 Julia Derk, PhD – A critical role for Wnt suppression in School of Medicine. The the development of the arachnoid barrier of the purpose of the meninges Symposium is to 2:45 Kelly Sullivan, PhD – Normalization of Interferon introduce research Receptor Gene Dosage in Mouse Model of Down performed in the Section Syndrome of Developmental Biology 3:00 Yunus Ozekin – Exploring the Effects of Prenatal to our St. Geme Lecturer, ECigarette Exposure on Craniofacial Development Dr. Nancy Bonini, 3:15 Jessica Warns, PhD – Does NF‐Y regulate cilia gene members of the St. Geme networks? family and the Anschutz 3:30 Kayt Scott – Prdm8 regulates pMN progenitor Medical Campus specification for motor neuron and oligodendrocyte community. fates by modulating Shh signaling response 3:45 Peter Dempsey, PhD ‐ Cellular Plasticity of Intestinal Secretory Progenitors in Response to Injury Zoom link https://ucdenver.zoom.us/j/921 40407653 Developmental Biology faculty, post-doctoral fellows About the Section of and student’s biographical information: Developmental Biology: Dempsey, Peter, PhD - Associate Professor Dr.
    [Show full text]
  • Temporal Patterns of Short Non-Coding Rna Modifications And
    TEMPORAL PATTERNS OF SHORT NON-CODING RNA MODIFICATIONS AND EXPRESSION by AMMAR S. NAQVI A dissertation submitted to the Graduate School – Camden Rutgers, The State University of New Jersey In partial fulfillment of the requirements For the degree of Doctor of Philosophy Graduate Program in Computational and Integrative Biology Written under the direction of Dr. Andrey Grigoriev And approved by ________________________ Andrey Grigoriev ________________________ Jongmin Nam ________________________ Nancy Bonini Camden, New Jersey May 2015 ABSTRACT OF THE DISSERTATION Temporal Patterns of non-coding RNA Modifications and Expression by AMMAR S. NAQVI Dissertation Director: Dr. Andrey Grigoriev We investigated the function and properties of small RNAs, particularly microRNAs and tRNA-derived fragments (tRFs) with age. We report the characterization of a novel 3'-to- 5' exonuclease, Nibbler (Nbr), that generates differing isoforms of miRNAs in Drosophila. We developed a robust approach to help identify and characterize 3' heterogeneity in microRNAs controlled by Nbr, which assisted in identifying age- associated traits, including neurodegeneration and lifespan. Subsequently, given the fact Nbr interacts with Ago1 and not Ago2, we observed an accumulation of certain isoforms, which lead us to ask if there were particular patterns and trends that were Ago-specific. Interestingly, we report a novel age-associated change of select isoforms with age that is Ago2 specific. RNA deep-sequencing analysis coupled with experimental evidence reflected an increased loading of miRNA isoforms into Ago2 with age. Essentially, the loss of methylated miRNAs led to accelerated brain degeneration and shortened lifespan. Intriguingly, we also observed and identified Ago-loaded tRFs, which appear to have properties similar to those of miRNAs.
    [Show full text]
  • TFEB/Mitf Links Impaired Nuclear Import to Autophagolysosomal
    RESEARCH ARTICLE TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9- ALS Kathleen M Cunningham1, Kirstin Maulding1, Kai Ruan2, Mumine Senturk3, Jonathan C Grima4,5, Hyun Sung2, Zhongyuan Zuo6, Helen Song2, Junli Gao7, Sandeep Dubey2, Jeffrey D Rothstein1,2,4,5, Ke Zhang7, Hugo J Bellen3,6,8,9,10, Thomas E Lloyd1,2,5* 1Cellular and Molecular Medicine Program, School of Medicine, Johns Hopkins University, Baltimore, United States; 2Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, United States; 3Program in Developmental Biology, Baylor College of Medicine (BCM), Houston, United States; 4Brain Science Institute, School of Medicine, Johns Hopkins University, Baltimore, United States; 5Solomon H. Snyder Department of Neuroscience, School of Medicine, Johns Hopkins University, Baltimore, United States; 6Department of Molecular and Human Genetics, BCM, Houston, United States; 7Department of Neuroscience, Mayo Clinic, Jacksonville, United States; 8Department of Neuroscience, BCM, Houston, United States; 9Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, United States; 10Howard Hughes Medical Institute, Houston, United States Abstract Disrupted nucleocytoplasmic transport (NCT) has been implicated in neurodegenerative disease pathogenesis; however, the mechanisms by which disrupted NCT causes neurodegeneration remain unclear. In a Drosophila screen, we identified ref(2)P/p62, a key regulator of autophagy, as a potent suppressor of neurodegeneration caused by the GGGGCC hexanucleotide repeat expansion (G4C2 HRE) in C9orf72 that causes amyotrophic lateral sclerosis *For correspondence: [email protected] (ALS) and frontotemporal dementia (FTD). We found that p62 is increased and forms ubiquitinated aggregates due to decreased autophagic cargo degradation. Immunofluorescence and electron Competing interest: See microscopy of Drosophila tissues demonstrate an accumulation of lysosome-like organelles that page 18 precedes neurodegeneration.
    [Show full text]
  • Polyq Expansions in Ataxin-2—A Risk Factor for Amyotrophic Lateral Sclerosis?
    RESEARCH HIGHLIGHTS MOTOR NEURON DISEASE PolyQ expansions in ataxin-2—a risk factor for amyotrophic lateral sclerosis? ntermediate-length polyglutamine (polyQ) expansions in the ataxin-2 I(ATXN2) gene could confer an increased risk of developing amyotrophic lateral sclerosis (ALS), according to research from a team led by Aaron Gitler and Nancy Bonini at the University of Pennsylvania, USA. Their findings indicate that ataxin-2 enhances the toxicity of TAR DNA-binding protein 43 (TDP-43)—a molecule that has already been strongly implicated in ALS pathogenesis—and the interaction between these two proteins could A combination of approaches involving yeast cells (left), Drosophila (center) and human motor neurons (right) has identified a provide a lead for the development of role for ataxin-2 in amyotrophic lateral sclerosis. Images provided by Professor Nancy Bonini and Professor Aaron Gitler. much-needed new therapies for ALS. Permission obtained from Nature Publishing Group © Elden, A. C. et al. Nature 466, 1069–1075 (2010). Long polyQ expansions (>34 glutamines) in the ATXN2 gene have overexpressed, increased TDP-43 toxicity. degradation, thereby increasing its previously been shown to cause the One of these genes was PBP1, the yeast concentration in the cell. hereditary neurodegenerative disease ortholog of ATXN2. These new findings identify ATXN2 spinocerebellar ataxia type 2 (SCA2). To examine the effects of the ATXN2– as a susceptibility gene for ALS, as well Gitler, Bonini and colleagues measured TDP-43 interaction in the context of as providing a number of avenues for ATXN2 polyQ repeat lengths in 915 the nervous system, the researchers further investigation of the underlying patients with sporadic or familial ALS, switched their attention to a Drosophila disease mechanisms.
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • NEWSLETTER VOLUME 35, NUMBER 6 Student/Postdoc- Led Local Meetings NIH Working Group Proposes Page 3 Training Changes More ASCB Award the Recommendations of a U.S
    ASCB J U L Y 2 0 1 2 NEWSLETTER VOLUME 35, NUMBER 6 Student/Postdoc- Led Local Meetings NIH Working Group Proposes Page 3 Training Changes More ASCB Award The recommendations of a U.S. National Institutes of Health (NIH) Working Group on the Announcements biomedical research workforce include changes in the programs offered by academic institutions, Page 8 limits on NIH support for graduate students, and changes in the way graduate students and postdocs are supported. The Working Group, a subcommittee of the Advisory Committee to An Innovative the NIH Director, was formed in January 2011 by NIH Director Francis Collins to examine Approach to Dual- the state of the biomedical research workforce and make recommendations to ensure the future Career Support competitiveness of the U.S. biomedical research enterprise. Page 11 The Biomedical Research Workforce Working Group was co-chaired by Shirley Tilghman and Sally Rockey, NIH Deputy Director for Extramural Research, and included ASCB members Leemor Joshua-Tor and Keith Yamamoto. In June 2012, the Working Group sent its report, with a series of recommendations, to Collins for his review and consideration. Inside Despite low unemployment for biomedical PhDs, the percentage of PhDs who move into President’s Column 3 tenured or tenure-track positions has declined by 8% since 1993. In contrast, science-related Did You Know? 6 occupations that do not involve the conduct of research or do not require graduate training WICB Junior, Senior Awards 8 are seeing increases in employment. According to
    [Show full text]
  • The Roles of MIST1 and RAB26 in Zymogenic (Chief) Cell Differentiation and Subcellular Organization" (2015)
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2015 The Roles of MIST1 and RAB26 in yZ mogenic (Chief) Cell Differentiation and Subcellular Organization Ramon Jin Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Biology Commons Recommended Citation Jin, Ramon, "The Roles of MIST1 and RAB26 in Zymogenic (Chief) Cell Differentiation and Subcellular Organization" (2015). Arts & Sciences Electronic Theses and Dissertations. 481. https://openscholarship.wustl.edu/art_sci_etds/481 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Molecular Cell Biology Dissertation Examination Committee: Jason C. Mills, Chair Paul H. Taghert, Co-Chair Stuart A. Kornfeld Indira U. Mysorekar Babak Razani Joel D. Schilling The Roles of MIST1 and RAB26 in Zymogenic (Chief) Cell Differentiation and Subcellular Organization by Ramon Jin A dissertation presented to the Graduate School of Arts & Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy
    [Show full text]
  • CV Yuanquan 3-23-16
    Yuanquan Song Ph.D. [email protected] Yuanquan Song Ph.D. Department of Physiology University of California San Francisco and HHMI 1550 4th Street RM RH481 San Francisco, CA 94158 (267) 679-9833 [email protected] Positions 05/2016 – Assistant Professor of Pathology and Laboratory Medicine Center for Cellular and Molecular Therapeutics (CCMT) at the Children's Hospital of Philadelphia (CHOP), University of Pennsylvania 09/2009 – 04/2016 Postdoctoral Fellow Dept. of Physiology, Univ. of California San Francisco and HHMI Mentor: Dr. Yuh Nung Jan, Ph.D. Education 05/2015 Spinal Cord Injury Training Program (SCITP) Dept. of Neuroscience, Ohio State University, Columbus, OH 2003 – 2009 Ph.D. in Neuroscience Univ. of Pennsylvania School of Medicine, Philadelphia, PA 1998 – 2002 B.S. in Biotechnology Shanghai Jiao Tong University, Shanghai, China Research Experience 09/2009 – present UCSF Yuh Nung Jan Lab Postdoctoral Fellow Research Projects: Cellular and molecular mechanisms underlying axon and dendrite degeneration and regeneration Neural and molecular substrates for the plasticity of aggression 02/2004 – 08/2009 UPenn Rita Balice-Gordon Lab Graduate Student Research Projects: Cellular and molecular mechanisms underlying neural circuitry formation and function Zebrafish model of MLL leukemogenesis Zebrafish model of neurodegenerative diseases 09/2003 – 12/2003 UPenn Irwin Levitan Lab Pre-dissertation Laboratory Rotation Research Project: Regulation of sodium-potassium ATPase by its binding protein mSlob 06/2003 – 08/2003 UPenn Nancy Bonini Lab Pre-dissertation Laboratory Rotation Research Project: Molecular mechanisms of polyglutamine diseases 07/2002 – 05/2003 Institute of Neuroscience, Academy of Sciences, Shanghai, China Research Assistant in the Lab of Shu-Min Duan, Xiao-Bing Yuan, and Mu-Ming Poo Research Project: Axon guidance and Rho GTPase signaling Awards and Fellowships 1 Yuanquan Song Ph.D.
    [Show full text]